Seshadri Neervannan - Mar 21, 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Mar 21, 2023
Transactions value $
-$14,324
Form type
4
Date filed
3/23/2023, 07:56 PM
Previous filing
Mar 21, 2023
Next filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale -$4.8K -372 -0.67% $12.89 55.5K Mar 21, 2023 Direct F1
transaction TARS Common Stock Sale -$4.79K -379 -0.68% $12.64 55.1K Mar 22, 2023 Direct F1
transaction TARS Common Stock Sale -$4.74K -390 -0.71% $12.15 54.7K Mar 23, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.